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Isothermal titration calorimetry (ITC) is conventionally used to acquire thermodynamic data 
for biological interactions. In recent years, ITC has emerged as a powerful tool to characterise 
enzyme kinetics. In this study, we have adapted a single-injection method (SIM) to study the 
kinetics of human soluble epoxide hydrolase (hsEH), an enzyme involved in cardiovascular 
homeostasis, hypertension, nociception and insulin sensitivity through the metabolism of 
epoxy-fatty acids (EpFAs). In the SIM method, the rate of reaction is determined by 
monitoring the thermal power while the substrate is being depleted, overcoming the need for 
synthetic substrates, and reducing postreaction processing. Our results show that ITC enables 
the detailed, rapid and reproducible characterisation of the hsEH-mediated hydrolysis of 
several natural EpFA substrates. Furthermore, we have applied a variant of the single-
injection ITC method for the detailed description of enzyme inhibition, proving the power of 
this approach in the rapid screening and discovery of new hsEH inhibitors using the enzyme’s 
physiological substrates. The methods described herein will enable further studies on EpFAs 
metabolism and biology, as well as drug discovery investigations to identify and characterise 
hsEH inhibitors. This also promises to provide a general approach for the characterisation of 
lipid catalysis, given the challenges that lipid metabolism studies pose to traditional 
spectroscopic techniques. 
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Human soluble Epoxide Hydrolase (hsEH – EC 3.3.2.10) is a bifunctional enzyme composed 
of two structurally and functionally independent domains.1,2 The C-terminal domain (CTD) is 
responsible for the hydrolysis of numerous epoxy-fatty acids (EpFAs), bioactive epoxidation 
products of mono- and polyunsaturated fatty acids with essential roles in cellular and 
organism homeostasis.2–4 hsEH CTD hydrolyses EpFAs via a SN2 nucleophilic attack by 
D335 on the more accessible carbon of the epoxide ring, forming an alkyl-enzyme 
intermediate, which is then released by the assisted action of D496 and H524.1,2,5 The 
catalytic triad is located in the vertex of a large ‘L-shaped’ active site, and is surrounded by 
two hydrophobic surfaces dubbed the W334 niche and the F265 pocket, wherein the aliphatic 
chains of the EpFAs are accommodated.1,2,4–6 
The best characterised EpFAs substrates of hsEH CTD are the epoxyeicosatrienoic acids 
(EETs), epoxy-derivatives of arachidonic acid (ARA)7 (Figure S1A). Although four EET 
regioisomers, namely 5(6)EET, 8(9)EET, 11(12)EET and 14(15)EET, have been isolated in 
several organs,8 the latter two have been shown to be the predominant ARA epoxidation 
metabolites.9 EETs function primarily as endothelial-derived hyperpolarising factors in the 
cardiovascular system and kidney.7 They play a role in vasorelaxation and vascular 
homeostasis, exerting anti-inflammatory and pro-angiogenic actions.7 The bioavailability of 
EETs is reduced by hsEH-mediated hydrolysis of their epoxy ring to generate the 
corresponding vicinal diols, namely dihydroxyeicosatrienoic acids (DHETs) (Figure S1A), 
which possess a considerably reduced biological activity.7 
In addition to EETs, hsEH hydrolyses several bioactive epoxy-derivatives of linoleic acid 
(LA) and α-linoleic acid (ALA), including α- and γ-epoxyoctadecadienoic acids (α/γ-
EpODEs), epoxyeicosatetraenoic acids (EpETEs), epoxydocosapentaenoic acids (EpDPEs), 
and epoxyoctadecaenoic acids (EpOMEs)10,11 (Figure S1B). The physiological role of α- and 
γ-EpODEs is yet unknown, although their hydrolysis products, the γ-dihydroxy-
octadecadienoic acids (γ-DiHODE), exhibit a moderate positive inotropic effect.12 EpETEs 
and EpDPEs show a similar breadth of activities to EETs.13 Vasodilation, antithrombotic, 
anti-angiogenic and anti-inflammatory effects have been ascribed to both EpETEs and 
EpDPEs, as well as diminished tumour growth and metastasis in murine models.10,14,15 
Interestingly, the hsEH-mediated hydrolysis product of 19(20)EpDPE, namely the 19(20)-
dihydroxy-docosapentaenoic acid (19(20)DiHDPE), accumulates in the retinas and vitreous 
humour of diabetic retinopathy patients, as a result of increased expression levels of the 
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enzyme, and aggravates disease severity by altering the localisation of cholesterol-binding 
proteins in the cell membrane, and leading to breakdown of endothelial barrier function.16 
Contrary to the largely beneficial physiological effects ascribed to other EpFAs, 9(10)- and 
12(13)EpOMEs inhibit mitochondrial respiration in various tissues, leading to cardiotoxicity, 
renal failure, and adult respiratory distress syndrome,17,18 albeit cytotoxicity is significantly 
increased in their sEH-catalysed products, the dihydroxy-octadecaenoic acids (DiHOMEs).17 
Interestingly, a Liquid Chromatography tandem Mass Spectrometry (LC-MS/MS) study 
revealed that hsEH displays different hydrolytic efficiency towards its various EpFA 
substrates.10 Although this work provided a first assessment of catalytic profiles for several 
epoxy fatty acids, potential drawbacks of this methodological approach include the following: 
(i) it is a discontinuous method, with potentially non-negligible experimental errors; (ii) it 
requires several sample manipulation steps that could lead to reproducibility issues; (iii) it is 
time consuming, technically challenging and expensive. Herein we present an Isothermal 
Titration Calorimetry (ITC)-based method for the systematic characterisation of hsEH 
catalytic efficiency towards its EpFAs substrates. By measuring the intrinsic heat of hsEH-
mediated hydrolysis of the epoxy-fatty acids in a continuous manner,19–23 our method 
circumvents the limiting issue of the lack of physicochemical properties of EpFAs 
substrates/products that can be monitored in real time in a continuous manner. 19–23 This new 
ITC application shows promise in the complete and highly reproducible characterisation of 
hsEH-mediated catalysis of epoxy-fatty acids, with relatively low sample amounts, low costs 
and rapid acquisition times.
The second goal of our study was to establish an easy and versatile method to measure 
inhibition properties of sEH antagonists against natural substrates. Given that dihydroxy-fatty 
acids generated by hsEH exhibit either cytotoxic effects or reduced biological activity 
compared to their epoxy precursors, pharmacological inhibition of hsEH has emerged as an 
extremely appealing therapeutic strategy to increase EpFAs bioavailability and reap their 
beneficial properties.24–26 Currently screening of hsEH inhibitors is mostly performed via a 
high-throughput spectrofluorimetric assay,27,28 a fast, economical and highly convenient 
method, that nonetheless carries the main drawback of not employing physiological 
substrates. To address this, we have adapted an ITC method developed by Di Trani et al.21 
Using a well-known hsEH antagonist as a model system we demonstrate here that this 
technique holds promise for the quantitative screening of new hsEH inhibitors using 
endogenous EpFAs substrates. 
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Enzyme, substrate and inhibitor sample preparation 
Recombinant hsEH CTD was obtained as described.29 This was shown to be necessary and 
sufficient for EpFA catalysis, and to retain the same kinetic profile as full length protein.29 
Protein, EpFAs substrates and inhibitor AUDA (12-[[(tricyclo[3.3.1.13,7]dec-1-
ylamino)carbonyl]amino]-dodecanoic acid) were prepared as reported in the Supporting 
information. 
Single-injection ITC kinetics measurements
The theoretical basis of kinetic measurements by ITC has been described19,22,30,31 and details 
are given in the Supporting information. Briefly, in a single injection ITC experiment the 
total heat measured is proportional to the apparent enthalpy (ΔHapp), and the number of moles 
of product generated. The reaction rate can be related to the amount of heat generated over 
time.  From the derived Michaelis–Menten plots the affinity for the substrate (KM), turnover 
rate (kcat), and catalytic efficiency (kcat/KM = Ksp) values can be obtained. 
Experiments were performed on MicroCal PEAQ-ITC and MicroCal iTC200 calorimeters 
(Malvern). An hsEH CTD solution at 250 nM was placed in the sample cell, and a 0.5-1.5 
mM substrate solution was loaded in the injection syringe. One single 38 μL injection was 
performed with a speed of 0.58-0.76 µL sec-1. Controls were carried out as described in the 
Supporting information. Apparent enthalpy of the reaction, heat rate (dQ/dt) and Michaelis–
Menten plots were generated using MicroCal PEAQ-ITC Analysis Software (Malvern). 
Progressive inhibition ITC enzyme kinetics measurements
A solution containing 0.5 mM of 14(15)EET and 67.37 nM of AUDA was  injected into the 
cell containing 250 nM of hsEH CTD. Four 9.5 μL injections of 12.5 seconds each were 
performed at a speed of 0.76 μL sec-1. Control experiments are described in the Supporting 
information. Apparent reaction enthalpy, dQ/dt rates and Michaelis–Menten parameters were 
generated using the MicroCal PEAQ-ITC Analysis Software (Malvern). Apparent KM values 
(KM') were obtained32 and data fitting in GraphPad provided KM'/Ki ratio20,21, where Ki is the 
inhibition constant. 
Inhibitory constant measurements with a spectrofluorometric method
AUDA inhibitory potency was tested with a spectrofluorometric method,28 detailed in the 
Supporting information.
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A single-injection ITC method characterises the kinetics of hsEH CTD-mediated 
hydrolysis of 14(15)EET 
To probe the kinetics of EpFA hydrolysis catalysed by hsEH CTD, we employed an ITC 
single-injection method (SIM).22,23 The substrate solution in the syringe of the calorimeter 
was injected in a single step into the sample cell containing the enzyme solution, producing a 
heat response which endured for as long as the reaction proceeds, returning to baseline when 
the reaction reached completion and all the substrate had been transformed into product. 
Rapid catalyses give rise to narrow peaks, whilst slow catalyses generate broad peaks. 
Whereas the total area of the peak depends on the amount of substrate injected and the 
apparent enthalpy of the reaction, its shape is governed by enzyme concentration, Michaelis–
Menten parameters, rate of substrate injection and intrinsic calorimeter response.19,21 
14(15)EET, the par excellence EpFA substrate of hsEH,8 was used as a test compound to 
demonstrate method-applicability and to set up the experimental conditions for this study. 
Optimisation included varying concentrations of substrate and enzyme, as well as reference 
power, injection speed and spacing. The curve obtained by injecting 14(15)EET into a 
solution of hsEH CTD was negative, narrow and deep, indicating a fast reaction (Figure 1A). 
The ΔHapp was calculated by integrating the area under the peak, and the Michaelis–Menten 
kinetics curve fitting was obtained by manually selecting the window between the end of the 
injection (maximum substrate concentration, corresponding to saturating enzyme conditions) 
and the end of the decaying portion of the injection (minimum substrate concentration, 
corresponding to the beginning of the kinetics curve) (Figure 1B). The software fitting 
calculates {[S]i; vi} data points through eq 2 and 3 (Supporting information), building a 
Michaelis–Menten curve (Figure 1C), thereby providing kcat and KM values. The catalytic 
efficiency (Ksp) was manually calculated as the kcat/KM ratio. In the optimal conditions, these 
experiments gave a kcat of 6.64 ± 1.54 sec-1 and a KM of 12.88 ± 1.94 µM for the hsEH-
mediated hydrolysis of 14(15)EET (Table 1). To assess any product inhibition effect, the 
ΔHapp of two subsequent injections was compared: no significant variation was observed 
(Figure S2A and S2B), demonstrating an absence of product inhibition for this hsEH CTD-
mediated hydrolysis reaction. 
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Kinetic characterisation of hsEH CTD-mediated hydrolysis of all EETs 
The experimental method and conditions optimised for 14(15)EET were applied to analyse 
the hsEH CTD-catalysed hydrolysis of the other regioisomeric EETs. Thermal profiles and 
Michaelis–Menten parameters significantly differed (Table 1). The hydrolysis of 5(6)EET 
generated a very small and broad peak (Figure 2A), indicating a low ΔHapp. Although it was 
possible to extrapolate a kcat value of 0.35 ± 0.05 sec-1 and a KM of 46.61 ± 10.98 µM, the 
error associated with this measurement was considerably greater than for the other EETs, due 
to the reduced magnitude of the heat response and the inability to reach enzyme saturation23. 
Attempts to perform the experiments with higher substrate concentration in fact resulted in 
precipitation of the mixture. The experiment with 8(9)EET and 11(12)EET gave a kcat of 1.28 
± 0.19 sec-1 and a KM of 23.10 ± 2.39 µM for the former and a kcat of 4.31 ± 0.16 sec-1 and a 
KM of 1.74 ± 0.20 µM for the latter. Control experiments to check for substrate 
autohydrolysis and product inhibition are reported in Figures S2B and S3.
 
Kinetic characterisation of hsEH CTD-mediated hydrolysis of n-3 and n-6 EpFAs
Beyond the EETs, the enzymatic activity of hsEH towards other EpFAs was measured by 
ITC. We selected two EpETEs, one EpDPE and one EpOME to cover the chemical scaffold 
diversity of hsEH substrates. Though belonging to the same chemical class, 8(9)EpETE and 
17(18)EpETE exhibited different enthalpy and kinetic values (Figure 3A and B, Table 1). 
The turnover rate for the 8(9)EpETE was 1.61 ± 0.01 sec-1, significantly higher than for the 
17(18)-regioisomer (0.64 ± 0.06 sec-1), and its KM (9.74 ± 0.13 µM) was almost three times 
lower than 17(18)EpETE (26.37 ± 4.05 µM). A broad negative peak in the thermal profile 
was also obtained for 19(20)EpDPE, indicating a slow hsEH CTD-mediated hydrolysis 
(Figure 3C) described by a turnover rate of 1.62 ± 0.08 µM and a KM of 26.60 ± 1.21 µM 
(Table 1). The hydrolysis of 12(13)EpOME gave rise to a narrow heat flow profile (Figure 
3D), similar to the ones observed for 11(12)- and 14(15)EET, with a kcat of 9.65 ± 0.19 sec-1 
and a KM of 2.98 ± 0.56 µM. As observed with the other substrates, negligible heat and 
product inhibition effects were observed in blank test injections (Figure S2B and S4).  
Characterisation of hsEH CTD inhibition using ITC
We adapted a protocol that builds on SIM ITC enzyme kinetic measurements21 to set up a 
versatile and continuous method to measure the inhibitory potency of hsEH antagonists 
against natural substrates, as well as readily characterise their mode of inhibition. We 
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evaluated the thermal power of 14(15)EET hydrolysis in the presence of the well-known 
hsEH inhibitor AUDA. The enzyme was placed in the calorimeter cell, whilst the syringe was 
loaded with a mixture of substrate and inhibitor. A series of injections was then performed 
(Figure 4A). In the experiment, AUDA accumulated in the sample cell with its concentration 
increasing 1-fold with each successive injection. This results in each injection producing a 
heat flow response that was progressively lower and broader than the preceding one, owing to 
increased hsEH CTD inhibition. Blank test injections showed little heat effects of 
substrate/inhibitor dilution into buffer (Figure S5A). Each peak injection was analysed 
individually to measure the ΔHapp and extract the Michaelis−Menten parameters. The kcat 
values derived from each peak were identical (8.89 ± 1.64 sec-1) and in agreement with the 
value detected in the absence of inhibitor (Table 1). The apparent KM (KM') for 14(15)EET 
increased at every successive injection with growing inhibitor concentration (Figure 4B). The 
kcat and KM' values obtained by this analysis indicate a model of competitive inhibition,32 
which is consistent with AUDA’s reported mode of action.26,33 As AUDA is a competitive 
inhibitor, the y-intercept of the KM' vs. AUDA concentration plot (Figure 4B) provides the 
true KM,32 measured as 11.91 ± 3.43 μM, in concurrence with the value for the 14(15)EET 
substrate obtained in the absence of inhibitor (Table 1). The analysis of the slope of the 
straight line fitted to the data points gives the KM'/Ki ratio,32 providing an average Ki for 
AUDA of 7.62 ± 2.81 nM. This is in excellent agreement with the value obtained from a 
spectrofluorimetric assay using the synthetic substrate PHOME28,29,34 (Figure S6A and B).  
Discussion
The study of EpFA catalysis mediated by hsEH is severely limited by the unavailability of 
fast, simple and effective methods to study their kinetics of hydrolysis. The only technique 
available thus far is a LC-MS/MS-based methodology,10 which, although highly sensitive, is 
a post-reaction ancillary technique, involving multiple steps of sample manipulation and 
analysis,32 and requiring highly specialised equipment and technical expertise. To develop a 
truly general, versatile and rapid enzyme kinetics assay, we have developed a single-injection 
ITC (SIM) approach. By detecting the heat released or absorbed in real time during catalysis, 
this technique follows reactions of native substrates without the need of detectable changes in 
physicochemical properties to track the concentration of substrate or product over time. The 
single-injection ITC method yields both thermodynamic and kinetic parameters in a single 
experiment. Recent advances in instrumentation faster response times and analysis software 
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(e.g. the new PEAQ-ITC analysis software) have allowed this approach to become more user-
friendly and routine. Compared to the multi-injection ITC method counterpart, the SIM is 
significantly faster, requires less enzyme, and is less subject to errors linked to baseline drift, 
or other time-dependent effects, including enzyme aggregation and/or precipitation and 
substrate degradation,19 because of the reduced experimental time and faster data 
acquisition.19,35
The ITC single-injection application presented here enables the rapid characterisation of 
kinetic parameters of various natural EpFA substrates of hsEH, such as EETs, EpETEs, 
EpDPEs and EpOMEs, using small amounts of protein and substrate, with each experiment 
taking on average 50 minutes (including washing and preparation of the instrument). To our 
knowledge this is the first example of the ITC SIM applied to lipid catalysis and it is the only 
method to date that allows a quantitative analysis of hsEH-mediated hydrolysis of EpFAs in a 
continuous manner. 
Our investigations revealed that all EpFAs tested could be hydrolysed by hsEH, albeit 
significant differences were observed in their kinetics profiles, in agreement with a previous 
study10. It is noteworthy that although data fitted well to the Michaelis-Menten model, hsEH 
CTD performs a two-step catalysis, undergoing first the formation of a covalent enzyme-
substrate alkyl intermediate followed by its hydrolysis.4,36 In these cases, KM values describe 
the concentration of the substrate for which the catalytic rate is half maximal, instead of 
providing an accurate measure of the substrate affinity for the enzyme,37 and kcat values 
represent mainly the hydrolysis rate of the covalent intermediate, given that this second step 
of the hsEH CTD-mediated catalysis is at least an order of magnitude slower than the first 
(formation of the alkyl covalent intermediate).4,36
Our results (Table 1) indicate that KM and kcat values vary significantly depending on the 
chemical scaffold and the epoxide position on the fatty acid structure. Whereas variations of 
KM values could not easily be correlated with substrate properties in this study, in general kcat 
values were the largest when the epoxide was central, on the carbon positions 11, 12 and 14 
of the fatty acid chain. Comparison of catalytic efficiency (Ksp), a measurement of the overall 
rate of the reaction and specificity of an enzyme for a substrate,37 revealed the preferred 
EpFA targets for hsEH CTD, summarised in a heatmap (Figure 5). For the substrates tested in 
our study, the rank order of hsEH CTD catalytic preference is 12(13)EpOME > 11(12)EET > 
14(15)EET > 8(9)EpETE > 19(20)EpDPE ≈ 8(9)EET > 17(18)EpETE > 5(6)EET. A trend is 
revealed here, correlating catalytic efficiency with the position of the epoxide function: hsEH 
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CTD distinctly prefers epoxides located in the middle of the fatty acid chain, at positions 11, 
12 and 14, with its activity steadily decreasing for substrates bearing the epoxide moiety 
closer to either the carboxyl acid group or to the methyl group at the end of the hydrocarbon 
chain. Having the epoxide close the carboxyl function is the least preferred configuration, as 
indicated by the lowest efficiency for 5(6)EET. This appears consistent with the narrow ‘L-
shaped’ hsEH CTD active site, with the catalytic triad positioned deep in the vertex and 
surrounded by two large hydrophobic regions.1,6 Notably, the overall substrate preference for 
sEH revealed by ITC is largely in agreement with what was previously observed in 
Morisseau et al.10 by LC-MS/MS, although it is noteworthy that the discrete Michaelis-
Menten parameters do differ in the two studies (especially kcat,). 
Given that hsEH inhibition is a potential therapeutic approach in a number of pathological 
conditions, the detailed knowledge of hsEH catalytic efficiency towards its various substrates 
is of great importance, as it will inform on how such an inhibition will affect the metabolism 
of several EpFAs, enabling the prediction of the expected outcome from their altered levels. 
As the relative abundance of each epoxy-fatty acid varies within the organism,10,13 a 
pharmacological intervention may have simultaneous assorted responses in different tissues 
and organs.
In addition to measuring the kinetics of catalysis for different EpFA targets of hsEH, we also 
devised an ITC method to screen new hsEH inhibitors using natural substrates. Our ITC 
application brings significant advantages. First, it evaluates inhibitor potency using hsEH 
physiological substrates, circumventing the problems associated with employing non-native 
fluorogenic compounds. This will have a particular bearing for the analysis of non-
competitive and mixed inhibitors, which bind respectively to the enzyme-substrate complex 
or both to enzyme and substrate.32 Interestingly, new allosteric inhibitors of hsEH have 
started to emerge,34 increasing the timely relevance of this new methodology. Furthermore, as 
the efficacy of non-competitive and mixed inhibitors may in principle differ from substrate to 
substrate, our ITC method offers a well-suited solution for a systematic characterisation of 
inhibition versus a battery of EpFA substrates. As a second major benefit, the ITC method 
allows for a straightforward characterisation of the mode of inhibition (i.e. competitive, 
uncompetitive or non-competitive/mixed),32 which is critical to drug development as 
evaluating the inhibitory power, given that it reveals the nature of the inhibited state(s).
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Despite the crucial biological roles of hsEH in a variety of physiological and pathological 
states, a comprehensive understanding of its catalytic activity against a compendium of 
natural substrates remains inadequate. Equally, the availability of assays that characterise and 
screen hsEH inhibitors using native substrates has been limited to date. We have presented a 
novel, versatile, expedient and reliable ITC SIM application that has the potential to be 
adopted as method of choice to perform such characterisations. Being not reliant on specific 
physicochemical and spectroscopic properties, our method is ideally posed to facilitate the 
discovery of new putative epoxy substrates of hsEH. Moreover, calorimetric measurements 
can be performed in mixtures and suspensions, e.g. in cellular and crude tissue extracts, as 
well as allowing measurements over a range of biologically relevant conditions19,38 (pH, 
redox conditions, salt concentration etc.), thereby having the potential to contribute to 
advances of hsEH biology in health and disease. As recent discoveries suggest a role for 
hsEH in redox regulatory systems,39,40,34 our newly developed ITC method can be used to 
assess the impact of enzyme oxidative state on both catalysis and inhibition of EpFAs 
hydrolysis. 
Taken together, our results show the first proof-of-concept for kinetic characterisation and 
inhibitor screening of hsEH activities using ITC, an approach which is generally applicable to 
other enzymes involved in lipid metabolism and should help in the search for novel inhibitors 
of this important class of enzymes.
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Supporting Information is available. It comprises 7 Figures and one Table reporting a 
schematic of the EpFAs metabolism, all the experimental controls and the spectrofluorimetric 
analysis of hsEH CTD inhibition. It also includes full experimental procedures and protocols, 
as well as a full mathematical treatment of the theoretical basis of kinetic rates determination 
by ITC. 
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Substrate ΔHapp [kJ mol-1] kcat [sec-1] KM [μM] Ksp [sec-1 μM-1]
5(6)EET -4.84 ± 0.65 0.35 ± 0.05 46.61 ± 10.98 0.01± 0.001
8(9)EET -39.45 ± 3.88 1.28 ± 0.19 23.10 ± 2.39 0.054 ± 0.010
11(12)EET -12.43 ± 0.62 4.31 ± 0.16 1.74 ± 0.20 2.53 ± 0.25
14(15)EET -23.72 ± 3.46 6.64 ± 1.54 12.88 ± 1.94 0.527 ± 0.075
8(9)EpETE -34.13 ± 0.93 1.61 ± 0.01 9.74 ± 0.13 0.173 ± 0.006
17(18)EpETE -51.78 ± 1.73 0.64 ± 0.06 26.37 ± 4.05 0.025 ± 0.003
19(20)EpDPE -23.73 ± 1.82 1.62 ± 0.08 26.60 ± 1.21 0.061 ± 0.003
12(13)EpOME -5.67 ± 0.38 9.65 ± 0.19 2.98 ± 0.56 3.56 ± 0.86
Table 1. Mean and standard error values for the apparent enthalpy and kinetics parameters of 
hsEH CTD-mediated hydrolysis of the EpFAs analysed in this study. The values were 
obtained as described in the methods. 
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Figure 1. Quantitative characterisation of hsEH-mediated hydrolysis of 14(15)EET. (A) 
Representative thermal profile of a single-injection of 14(15)EET into hsEH CTD. (B) 
Screenshot from the MicroCal PEAQ-ITC Analysis Software. The ΔHapp was calculated by 
integrating the area under the peak (violet), upon definition of the baseline through manual 
adjustments of the left markers workspace (green). The data points used for the Michaelis–
Menten kinetics curve fitting were obtained by manual adjustments of the right markers 
workspace (grey), selecting the window between the end of the injection (maximum substrate 
concentration – saturating enzyme conditions) and the end of the decaying portion of the peak 
(minimum substrate concentration – beginning of the kinetics curve). Note that the first part 
of the curve corresponding to substrate injection was not included in the rate plot analysis. 
(C) Representative Michaelis–Menten fit of the {[S]i;vi} data point extrapolated from B using 
the MicroCal PEAQ-ITC Analysis Software analysis. 
Figure 2. Single-injection isotherms and data fitting for the hsEH-mediated hydrolysis of 
EETs. Experiments are shown for (A) 5(6)EET; (B) 8(9)EET and (C) 11(12)EET. Each panel 
reports a representative thermal profile of a single-injection experiment (top plot) and the 
corresponding data fit using the Michaelis–Menten model (bottom plot). Note that the faster 
the reaction, the fewer data points will be available for fitting the plot. 
Figure 3. Single-injection isotherms and data fitting for the hsEH-mediated hydrolysis of 
EpFAs. Experiments are shown for (A) 8(9)EpETE; (B) 17(18)EpETE; (C) 19(20)EpDPE 
and (D) 12(13)EpOME. Each panel reports a representative thermal profile of a single-
injection experiment (top plot) and the corresponding data fit using the Michaelis–Menten 
model (bottom plot). Note that for faster reactions fewer data points will be available for 
fitting the plot.
Figure 4. hsEH CTD inhibition studies. (A) Representative thermal power of 
14(15)EET/AUDA injections into hsEH CTD. The magnitude of the peaks decreases with 
each successive injection due to the increased concentration of the inhibitor, whilst the slope 
of the recovery increased, suggesting a competitive mode of inhibition. (B) Linear KM' vs. 
AUDA concentration fitting from data shown in (A). 
Figure 5. Heatmap of the kinetics parameters of the hsEH CTD-mediated hydrolysis of 
EpFAs showing Ksp. inverse of KM (KM-1 [µM-1]) and kcat. Colours span from grey to dark red 
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with increasing values. Each shade of grey-to-red indicates an increase of the 12.5th percentile 
of the total interval of values. A combination of dark red shades indicates high affinity, 
turnover rate, and efficiency. 
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